Effectiveness of an Antioxidant in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty: The Probucol Angioplasty Restenosis Trial
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 30 (4) , 855-862
- https://doi.org/10.1016/s0735-1097(97)00270-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Effectiveness of Probucol in Preventing Restenosis after Percutaneous Transluminal Coronary Angioplasty.Japanese Heart Journal, 1996
- Inhibition of Hypercholesterolemia-Induced Atherosclerosis in the Nonhuman Primate by ProbucolArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Natural antioxidants and restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1995
- Combination of Vitamins C and E Alters the Response to Coronary Balloon Injury in the PigArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Molecular biology: Insight into the causes and prevention of restenosis after arterial interventionThe American Journal of Cardiology, 1993
- d‐α‐Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cellsFEBS Letters, 1993
- Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA).Journal of the American College of Nutrition, 1992
- Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosisThe American Journal of Cardiology, 1988
- Probucol, high-density lipoprotein metabolism and reverse cholesterol transportThe American Journal of Cardiology, 1988
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984